Clinical Trial Imaging Market Size To Reach $1.97 Billion By 2030

November 2023 | Report Format: Electronic (PDF)

Clinical Trial Imaging Market Growth & Trends

The globalclinical trial imaging marketsize is expected to reach USD 1.97 billion by 2030, registering a CAGR of 7.60% during the forecast period, according to a new report by Grand View Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging inclinical trialsis used as a primary, quantitative, and surrogate biomarker.

The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities such as EMA and FDA to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials inneuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuro-imaging. Imaging biomarkers are effective in radiological reads. This provides the reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility

---

Request a free sample copy or view report summary:Clinical Trial Imaging Market Report

---

Clinical Trial Imaging Market Report Highlights

• 箴ject and Data Management Services held the largest share in 2023 due to the growing requirement for data management and workflow for clinical trial imaging

• Operational imaging services held a significant share in 2023 and include imaging modalities such as MRI, CT scan, Ultrasound, Optical Coherence Tomography (OCT), X-rays, and others

• The oncology segment held the largest share in 2023. High prevalence of cancer cases and the constant need for new and innovative therapies to treat various types of cancer are expected to fuel the market growth.

• CROs held the largest share in 2023 due to increasing investments in the field of research and development, snowballing outsourcing activities by the pharmaceutical and biotechnology companies to cut down the cost and time, and patent expiration

• North America dominated this market with the largest share in 2023 due to the increasing geriatric population, along with chronic diseases and growing demand for treatment options.

Clinical Trial Imaging Market Segmentation

Grand View Research has segmented the global clinical trial imaging market based on service, application, end-use, and region:

Clinical Trial ImagingService Outlook (Revenue, USD Million, 2018 - 2030)

• Clinical Trial Design & Consultation Services

• Reading & Analytical Services

• Operational Imaging Services

  • Computed Tomography (CT) Scan

  • MRI (Magnetic Resonance Imaging)

  • X-Ray

  • Ultrasound

  • Optical Coherence Tomography (OCT)

  • Others

• System & Technology Support Services

• 箴ject & Data Management

Clinical Trial ImagingApplication Outlook (Revenue, USD Million, 2018 - 2030)

• NASH

• CKD

• Diabetes

• Cardiovascular Diseases

• Musculoskeletal

• Oncology

• Gastroenterology

• 儿科

• Others

Clinical Trial ImagingEnd-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biotechnology & Pharmaceutical companies

• Medical Devices Manufacturers

• Academic & Government Research Institutes

• Contract Research Organizations (CROs)

• Others

Clinical Trial ImagingRegional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • India

  • China

  • Japan

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Clinical Trial Imaging Market

• IXICO plc

• Navitas Life Sciences

• Resonance Health

• 箴Scan Imaging

• Radiant Sage LLC

• Medpace

• Biomedical Systems Corp

• Cardiovascular Imaging Technologies

• Intrinsic Imaging

• BioTelemetry